This paper is in the following e-collection/theme issue:

COVID-19 Vaccination (155) JMIR Theme Issue: COVID-19 Special Issue (2461) Vaccination and Immunization in the Digital Age (378) Infectious Diseases (non-STD/STI) (1594)

Published on in Vol 8, No 5 (2022): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35054, first published .
The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence

The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence

The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence

Authors of this article:

Luis Rosero-Bixby1 Author Orcid Image
Article Authors Cited by (4) Tweetations (3) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.